Elsevier

Dublin – October 15, 2026 -- Elsevier has pledged 4,000 complimentary AI product licenses and an estimated €1m a year in in-kind support and funding to the European Commission's AI in Science Enablers Initiative.

The commitment was announced at the AI in Science Summit in Dublin. More than 1,000 participants from the research, technology, business and policy communities attended the event, which launched the Commission's effort to mobilize private-sector and philanthropic support for European science.

Elsevier splits 4,000 licenses evenly across four AI and clinical products

Elsevier will provide 1,000 licenses each for four products to European researchers, healthcare professionals and students:

New York – October 07, 2026 -- Elsevier has signed a strategic content agreement with the JAMA Network to integrate full-text content and visuals from 13 JAMA journals into ClinicalKey AI, its clinical-grade AI workspace, giving clinicians access to more than half of the world's top 100 medical journals through the platform.

Agreement covers 13 JAMA Network titles including flagship journal and specialty publications

The deal brings all published full-text content and visuals from JAMA, JAMA Network Open, and 11 specialty journals -- JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery -- into the responses clinicians receive through ClinicalKey AI. Content is available to ClinicalKey AI customers immediately.